Blue Trust Inc’s Immunocore IMCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-6
Closed -$178 2531
2025
Q1
$178 Hold
6
﹤0.01% 2428
2024
Q4
$177 Sell
6
-230
-97% -$7.27K ﹤0.01% 2387
2024
Q3
$8K Buy
236
+158
+203% +$5.75K ﹤0.01% 2271
2024
Q2
$5.07K Buy
+78
New +$3.98K ﹤0.01% 2200
2024
Q1
Sell
-34
Closed -$2K 2448
2023
Q4
$2K Buy
+34
New +$1.77K ﹤0.01% 2156

Other funds holding IMCR

Blue Trust Inc's IMCR Position: Q2 2025 in Review

Blue Trust Inc sold out of Immunocore (IMCR) in Q2 2025, closing a stake of 6 shares — an estimated $178 sold.

Blue Trust Inc first reported a position in IMCR in Q4 2023 and held it in 5 quarters. The position peaked at $8K in Q3 2024. 133 funds tracked by Wall St. Rank hold IMCR as of Q2 2025.

  • Blue Trust Inc reported no remaining Immunocore position as of Q2 2025 after selling out during the quarter.
  • Blue Trust Inc sold 6 Immunocore shares in Q2 2025, an estimated $178.
  • Blue Trust Inc first reported a position in Immunocore in Q4 2023 and held it in 5 quarters.
  • Blue Trust Inc's Immunocore position peaked at $8K in Q3 2024.
  • 133 funds tracked by Wall St. Rank held Immunocore as of Q2 2025.

Based on Blue Trust Inc's 13F filing for Q2 2025, filed 24 Jul 2025.